Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain
Jia Nong, Patrick M. Glassman, Jacob W. Myerson, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13121-13136
Closed Access | Times Cited: 20

Showing 20 citing articles:

Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Shuai Zha, Haitao Liu, Hengde Li, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1820-1845
Open Access | Times Cited: 89
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
Jia Nong, Patrick M. Glassman, Vladimir V. Shuvaev, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1344-1358
Open Access | Times Cited: 28
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 10
Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium
Xiuxiu Cong, Zebin Zhang, He Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Extracellular vesicle surface engineering with integrins (ITGAL & ITGB2) to specifically target ICAM-1-expressing endothelial cells
Markus Bergqvist, Kyong‐Su Park, Nasibeh Karimi, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage
Sahily Reyes‐Esteves, Jia Nong, Patrick M. Glassman, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 185-195
Open Access | Times Cited: 22
Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders
Yu Wu, Angelina Angelova
Nanomaterials (2023) Vol. 13, Iss. 23, pp. 3004-3004
Open Access | Times Cited: 22
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders
Marina Placci, Marina I. Giannotti, Silvia Muro
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114683-114683
Open Access | Times Cited: 19
Blood–Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma
Yulin Zhang, Kaiyan Xi, Yuying Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9511-9524
Closed Access | Times Cited: 4
Design Considerations for Organ-Selective Nanoparticles
Min‐Jun Baek, Won Hur, Satoshi Kashiwagi, et al.
ACS Nano (2025)
Closed Access
RNA–lipid nanoparticles for acute critical illnesses
Serena Omo‐Lamai, Marco E. Zamora, Bruce A. Mueller, et al.
Nature Reviews Bioengineering (2025)
Closed Access
Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
Kang Wang, Rui Yang, Jing Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming
Hannia V. Balcorta, Veronica Guerrero, Deepali Bisht, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 5020-5036
Closed Access | Times Cited: 3
Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting
Marco E. Zamora, Serena Omo‐Lamai, Manthan N. Patel, et al.
Nano Letters (2024)
Open Access | Times Cited: 3
Noble Nanomedicine: Celebrating Groundbreaking mRNA Vaccine Innovations
Warren C. W. Chan, Natalie Artzi, Chunying Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19476-19477
Closed Access | Times Cited: 7
New Cellular Models to Support Preclinical Studies on ICAM-1-Targeted Drug Delivery
Marco Vigo, Elena Haro-Martínez, Eloy Ruiz, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106170-106170
Closed Access | Times Cited: 2
ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine
Zhengyang Quan, Sa Wang, Huanhuan Xie, et al.
Small (2024)
Closed Access | Times Cited: 2
Chronotherapeutics for Solid Tumors
Claire O. Kisamore, Brittany D. Elliott, A. Courtney DeVries, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2023-2023
Open Access | Times Cited: 6
Nanoparticle-mediated delivery of non-viral gene editing technology to the brain
Lucian Williams, Jessica Larsen
Progress in Neurobiology (2023) Vol. 232, pp. 102547-102547
Open Access | Times Cited: 6
Modulating active targeting nanoparticle design according to tumor progressions
Huifang Nie, Rong Huang, Guangwei Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 1143-1158
Open Access
Presence of ICAM-1 Isoforms in Human Cells Impacts the Selection of Antibodies for Nanocarrier Targeting
Marco Vigo, Marina Placci, Silvia Muro
Journal of Drug Delivery Science and Technology (2024), pp. 106582-106582
Closed Access
A combination of physicochemical tropism and affinity moiety targeting of lipid nanoparticles enhances organ targeting
Marco E. Zamora, Serena Omo‐Lamai, Manthan N. Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top